Healthcare provider profile · identity verified

Scott Kenneth Andrews, MD

Family Practice · LEWISTOWN, PA · NPI 1124170089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	862	245
Levothyroxine Sodium	Levothyroxine Sodium	483	124
Omeprazole	Omeprazole	424	116
Lisinopril	Lisinopril	396	112
Amlodipine Besylate	Amlodipine Besylate	389	105
Metformin Hcl	Metformin Hcl	324	90
Losartan Potassium	Losartan Potassium	320	90
Rosuvastatin Calcium	Rosuvastatin Calcium	243	68
Simvastatin	Simvastatin	231	60
Hydrochlorothiazide	Hydrochlorothiazide	211	61
Metoprolol Succinate	Metoprolol Succinate	205	58
Pantoprazole Sodium	Pantoprazole Sodium	188	50
Metoprolol Tartrate	Metoprolol Tartrate	186	52
Ozempic	Semaglutide	180	29
Eliquis	Apixaban	176	43
Montelukast Sodium	Montelukast Sodium	170	40
Furosemide	Furosemide	169	53
Metformin Hcl Er	Metformin Hcl	154	43
Tamsulosin Hcl	Tamsulosin Hcl	147	44
Gabapentin	Gabapentin	146	47
Jardiance	Empagliflozin	146	40
Warfarin Sodium	Warfarin Sodium	146	44
Albuterol Sulfate Hfa	Albuterol Sulfate	137	53
Sertraline Hcl	Sertraline Hcl	130	37
Potassium Chloride	Potassium Chloride	121	32
Pregabalin	Pregabalin	119	26
Fluticasone Propionate	Fluticasone Propionate	118	34
Alendronate Sodium	Alendronate Sodium	111	33
Famotidine	Famotidine	108	29
Duloxetine Hcl	Duloxetine Hcl	105	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	104	31
Atenolol	Atenolol	100	31
Clopidogrel	Clopidogrel Bisulfate	95	29
Allopurinol	Allopurinol	92	27
Glipizide Er	Glipizide	77	21
Ezetimibe	Ezetimibe	75	19
Escitalopram Oxalate	Escitalopram Oxalate	66	18
Pravastatin Sodium	Pravastatin Sodium	64	18
Finasteride	Finasteride	63	19
Trazodone Hcl	Trazodone Hcl	63	20
Hydroxyzine Hcl	Hydroxyzine Hcl	61	15
Carvedilol	Carvedilol	55	16
Citalopram Hbr	Citalopram Hydrobromide	52	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	18
Meloxicam	Meloxicam	50	12
Memantine Hcl	Memantine Hcl	49	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	46	11
Baclofen	Baclofen	45	13
Breo Ellipta	Fluticasone/Vilanterol	44	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Mounjaro	Tirzepatide	39	suppressed
Mirtazapine	Mirtazapine	36	11
Alprazolam	Alprazolam	35	suppressed
Glipizide	Glipizide	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Donepezil Hcl	Donepezil Hcl	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Klor-Con M20	Potassium Chloride	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Amoxicillin	Amoxicillin	29	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	12
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Valsartan	Valsartan	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Nystatin	Nystatin	24	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	11
Novolog Flexpen	Insulin Aspart	22	suppressed
Prednisone	Prednisone	22	11
Unifine Pentips	Pen Needle, Diabetic	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Temazepam	Temazepam	21	suppressed
Torsemide	Torsemide	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Naproxen	Naproxen	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nitroglycerin	Nitroglycerin	19	12
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Topiramate	Topiramate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Synthroid	Levothyroxine Sodium	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error